OTOPET TERAPIA
OTOPET TERAPIA
Authorised
- COLISTIN SULFATE
- Carbaril
- Miconazole
- Triamcinolone acetonide
- Rifaximin
Product identification
Medicine name:
OTOPET TERAPIA
Active substance:
- COLISTIN SULFATE
- Carbaril
- Miconazole
- Triamcinolone acetonide
- Rifaximin
Target species:
-
Dog
-
Cat
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
COLISTIN SULFATE200000.00/international unit(s)1.00millilitre(s)
-
Carbaril10.00/milligram(s)1.00millilitre(s)
-
Miconazole17.40/milligram(s)1.00millilitre(s)
-
Triamcinolone acetonide1.00/milligram(s)1.00millilitre(s)
-
Rifaximin10.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Ear drops, suspension
Withdrawal period by route of administration:
-
Auricular use
-
Dog
-
Unspecified0day
-
-
Cat
-
Unspecified0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Available in:
-
Italy
Package description:
- Available only in Italian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 14/03/2026